Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing

PURPOSE: Exome sequencing of a single individual for a clinical indication may result in the identification of incidental deleterious variants unrelated to the indication for testing (secondary findings). Given the recent availability of clinical exome testing, there is a limited knowledge regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahmirzadi, Layla, Chao, Elizabeth C., Palmaer, Erika, Parra, Melissa C., Tang, Sha, Gonzalez, Kelly D. Farwell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018499/
https://www.ncbi.nlm.nih.gov/pubmed/24113345
http://dx.doi.org/10.1038/gim.2013.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018499/
https://www.ncbi.nlm.nih.gov/pubmed/24113345
http://dx.doi.org/10.1038/gim.2013.153

Ejemplares similares